tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IRWD Stock Latest News

Ironwood Pharmaceuticals Reports Strong Q2 2025 Results
Company AnnouncementsIronwood Pharmaceuticals Reports Strong Q2 2025 Results
21d ago
IRWD
Ironwood Pharmaceuticals (IRWD) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Ironwood Pharmaceuticals (IRWD) Q2 Earnings Cheat Sheet
24d ago
IRWD
Ironwood Pharma Elects Directors at Annual Meeting
PremiumCompany Announcements
Ironwood Pharma Elects Directors at Annual Meeting
3M ago
8K
IRWD
Ironwood Pharma Receives Nasdaq Deficiency Letter
PremiumCompany Announcements
Ironwood Pharma Receives Nasdaq Deficiency Letter
3M ago
8K
IRWD
Ironwood Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany Announcements
Ironwood Pharmaceuticals Reports Q1 2025 Financial Results
4M ago
IRWD
Ironwood reports Q1 EPS (14c), two estimates (3c)
PremiumThe FlyIronwood reports Q1 EPS (14c), two estimates (3c)
4M ago
IRWD
Ironwood affirms FY25 revenue $260M-$290M, consensus $286.8M
Premium
The Fly
Ironwood affirms FY25 revenue $260M-$290M, consensus $286.8M
4M ago
IRWD
Ironwood Pharma: Hold Rating Maintained Amid Revenue Uncertainty and Long-term Concerns
Premium
Ratings
Ironwood Pharma: Hold Rating Maintained Amid Revenue Uncertainty and Long-term Concerns
4M ago
IRWD
IRWD Earnings this Week: How Will it Perform?
PremiumPre-Earnings
IRWD Earnings this Week: How Will it Perform?
4M ago
IRWD
Ironwood backs FY25 revenue view $260M-$290M, consensus $287.07M
PremiumThe Fly
Ironwood backs FY25 revenue view $260M-$290M, consensus $287.07M
4M ago
IRWD
Ironwood downgraded to Hold from Buy at Craig-Hallum
PremiumThe Fly
Ironwood downgraded to Hold from Buy at Craig-Hallum
4M ago
IRWD
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
PremiumRatings
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
5M ago
IRWD
Ironwood downgraded to Hold from Buy at Jefferies
PremiumThe FlyIronwood downgraded to Hold from Buy at Jefferies
5M ago
IRWD
Hold Rating on Ironwood Pharma Amid FDA Trial Requirements and Strategic Uncertainties
Premium
Ratings
Hold Rating on Ironwood Pharma Amid FDA Trial Requirements and Strategic Uncertainties
5M ago
IRWD
Ironwood downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Ironwood downgraded to Equal Weight from Overweight at Wells Fargo
5M ago
IRWD
Wells downgrades Ironwood to Equal Weight on ‘major setback’
PremiumThe Fly
Wells downgrades Ironwood to Equal Weight on ‘major setback’
5M ago
IRWD
Ironwood price target lowered to $1 from $3 at Leerink
PremiumThe Fly
Ironwood price target lowered to $1 from $3 at Leerink
5M ago
IRWD
Citizens JMP downgrades Ironwood on delayed apraglutide launch
PremiumThe Fly
Citizens JMP downgrades Ironwood on delayed apraglutide launch
5M ago
IRWD
Ironwood downgraded to Market Perform from Outperform at Citizens JMP
PremiumThe Fly
Ironwood downgraded to Market Perform from Outperform at Citizens JMP
5M ago
IRWD
Morning Movers: Goldman Sachs gains following first quarter results
PremiumThe FlyMorning Movers: Goldman Sachs gains following first quarter results
5M ago
GS
BKD
Ironwood needs trial for apraglutide approval, initiates strategic review
Premium
The Fly
Ironwood needs trial for apraglutide approval, initiates strategic review
5M ago
IRWD
Ironwood Pharmaceuticals: Stability and Growth Potential Amid Internal Control Improvements
Premium
Ratings
Ironwood Pharmaceuticals: Stability and Growth Potential Amid Internal Control Improvements
5M ago
IRWD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >